Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2005
06/08/2005CN1623990A Carbazole-containing compound and organic electroluminescence display device using the compound
06/08/2005CN1623984A Fused-ring compounds and use thereof as drugs
06/08/2005CN1205202C N-carbanilides used as pesticides
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/07/2005US6903223 Phenyldiazirine compounds and photoaffinity labeling reagent
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903123 Antitussive agents, anxiolytic agents, analgesics for treating cough, anxiety and pain
06/07/2005US6903117 Indole derivatives for the treatment of osteoporosis
06/07/2005US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders
06/07/2005US6903104 Antitumor agents, anticarcinogenic agents, a 3-oxoacetamideindolyl compounds, for treating cancer, cytotoxic, and angiogensis inhibitors
06/07/2005US6903103 Linear cyclic ureas
06/07/2005US6903101 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
06/07/2005US6903098 Use of phthalazine derivatives
06/07/2005US6903096 Quinazoline derivatives as medicaments
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903079 Nucleoside compounds and compositions thereof
06/07/2005CA2244139C Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
06/07/2005CA2186039C New oral pharmaceutical dosage form
06/02/2005WO2005051046A1 Light-emitting device, organic compound and display
06/02/2005WO2005049607A1 Triazine dimers for the treatment of autoimmune diseases
06/02/2005WO2005049606A1 Heteroaryl derivatives as ppar activators
06/02/2005WO2005049605A1 Antibacterial aminoquinazolidinedione derivatives
06/02/2005WO2005049594A1 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049593A2 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049581A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/02/2005WO2005049579A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
06/02/2005WO2005049565A1 N-sulfonyldicarboximide containing tethering compounds
06/02/2005WO2005049564A1 Amide derivatives and methods of their use
06/02/2005WO2005049033A1 Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
06/02/2005WO2005049019A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
06/02/2005WO2005048922A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
06/02/2005WO2005037821A3 Preparation of candesartan cilexetil
06/02/2005WO2005035528A3 Triazole derivatives as antibacterial agents
06/02/2005WO2005027823A3 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
06/02/2005WO2005016879A3 Cyclic pyrazinoylguanidine sodium channel blockers
06/02/2005US20050119489 Antidiabetic, anorexigenic, hypotensive, and anticholesterol agents that are synergistically combined with other active agents; obesity, premenstrual tension, hyperlipidemia, myocardial infarction and skin disorders
06/02/2005US20050119488 Phenyltetrazole compounds
06/02/2005US20050119484 Mitotic kinesin inhibitors
06/02/2005US20050119453 Method of removing transition metals
06/02/2005US20050119329 Tetronic and tetramic acids
06/02/2005US20050119291 Pyrimidine compounds
06/02/2005US20050119290 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents
06/02/2005US20050119274 3-[5-chloro-6-methyl-2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yl]-4-( 1H-indol-3-yl)-pyrrole-2,5-dione; T lymphocytes, Protein Kinase C (PKC) and glycogen synthase kinase 3 beta (GSK3B) mediated diseases;
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119268 Treatment of CRTH2-mediated diseases and conditions
06/02/2005US20050119260 5-(7-Chloro-1-methyl-1H-indol-3-ylmethyl)-3-methyl-imidazolidine-2,4-dione; neurodegenerative and necrotic cell disease; non-apoptotic/caspase-independent cell death mechanisms; ischemia, stroke, cardiac infarction, infection and sepsis
06/02/2005US20050119255 Phenylpyrimidine amines as ige inhibitors
06/02/2005US20050119252 Ligands of melanocortin receptors and compositions and methods related thereto
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119246 2-(4-{[1-(2,2-dimethylpropanoyl)-4-piperidinyl]methyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-methylethylcarbamate; appetite suppressants; obesity, diabetes, feeding behavior, bulimia, anorexia nervosa and premenstrual tension; side effect reduction
06/02/2005US20050119231 Quinolone antibiotics such as 3-Amino-1-cyclopropyl-6-fluoro-7-(3-hydroxymethyl-pyrrolidin-1-yl)-8-methoxy-1H-quinazoline-2,4-dione, used for treating gramnegative or grampositive bacterial infection in mammals
06/02/2005US20050119227 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/02/2005US20050119168 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
06/02/2005US20050119128 Substituted 4-hetaryl-pyrazolines as pest control agents
06/02/2005US20050118255 non-hygroscopic, crystalline anhydrous maleate salt of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene) methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
06/02/2005DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
06/02/2005CA2554635A1 Compounds, compositions containing such compounds and methods of treatment of autoimmune diseases using such compounds
06/02/2005CA2546339A1 Antibacterial aminoquinazolidinedione derivatives
06/02/2005CA2545193A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/02/2005CA2543239A1 Heteroaryl derivatives as ppar activators
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1535906A1 Nitrogen-containing compounds
06/01/2005EP1535904A2 Process for the preparation of optically active 1-(4-nitrophenyl)-3-pyrrolidinole derivatives, paraphenylenediaines comprising chiral pyrrolidinyl groups
06/01/2005EP1534703A2 Antagonists of melanin concentrating hormone receptor
06/01/2005EP1534701A1 Substituted heterocyclylpyrimidines
06/01/2005EP1534695A2 Tyrosine kinase inhibitors
06/01/2005EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
06/01/2005EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
06/01/2005EP1534686A2 Nf-kb inhibitors and uses thereof
06/01/2005EP1534685A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors
06/01/2005EP1534681A1 Substituted quinoline ccr5 receptor antagonists
06/01/2005EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
06/01/2005EP1534279A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
06/01/2005EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
06/01/2005EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
06/01/2005EP1534268A2 Tyrosine kinase inhibitors
06/01/2005EP1351959B1 Novel pleuromutilin derivatives
06/01/2005EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
06/01/2005EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
06/01/2005EP0991625B1 Inhibitors of factor xa with a neutral p1 specificity group
06/01/2005EP0937715B1 Tetrahydrobenzindole compounds
06/01/2005CN1622948A Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
06/01/2005CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
06/01/2005CN1622925A Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
06/01/2005CN1622807A Phenylpyrimidine amines as IgE inhibitors
06/01/2005CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs.
06/01/2005CN1204137C Uracil compound and its appliance
06/01/2005CN1204121C 1, 4-substituted cyclic amine derivatives or dihydro indole derivatives and medicines containing same
06/01/2005CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy
05/2005
05/31/2005US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis
05/31/2005US6900336 8-aza-11-deoxy prostaglandin analogues
05/31/2005US6900230 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents
05/31/2005US6900220 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
05/31/2005US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
05/31/2005US6900211 CCR5 antagonists useful for treating aids
05/31/2005US6900207 N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient
05/31/2005US6900206 For therapy of HIV (human immunodeficiency virus-1) infectio and AIDS (acquired immunodeficiency syndrome)
05/26/2005WO2005047281A1 Novel herbicides
05/26/2005WO2005047280A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
05/26/2005WO2005047279A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 626